Instil Bio, Inc.

TIL Healthcare Biotechnology

In the quarter to June 2026, EPS grew 80.6%, free cash flow grew 68.6% and total debt was flat, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

5.91 0.22 −3.59%
Market cap
$41.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
8.90 241.71 454.10 260.92 151.86 115.15 76.30
Other current assets
0.39 4.42 9.92 8.46 — — 112.10
Total current assets
9.29 246.14 464.02 269.38 160.76 124.47 191.43
Property, Plant, Equpment (Net)
0.19 55.34 122.00 196.88 138.68 129.41 0.13
Long-Term Investments
— 0.05 0.50 — 23.16 — —
Long-term receivables
— — — — — 4.27 7.66
Goodwill and Intangible Assets (Total)
— 15.83 15.83 — — — —
Long-term assets (Other)
— 1.71 8.14 3.41 0.64 4.49 4.07
Total non-current assets
0.19 72.87 145.96 212.75 164.87 139.10 12.09
Total Assets
9.48 319.01 609.98 482.13 325.63 263.57 203.52
Accounts Payable
0.98 3.50 5.57 2.36 1.21 0.66 0.78
Accrued Expenses
0.44 8.40 34.45 30.07 9.35 7.24 4.06
Other current liabilities
0.44 1.38 1.34 0.36 — — —
Total current liabilities
1.42 13.28 41.36 32.79 10.56 7.90 4.84
Long Term Debt (Total)
— — — 72.35 81.43 84.19 84.81
Long Term Tax Liability (Deferred)
— 2.47 2.43 — — — —
Liabilities (Preferred Stock)
14.95 331.97 0.00 — — — —
Non-current Liabilities (Other)
— 10.89 11.00 8.21 4.94 1.03 0.01
Total non-current liabilities
14.95 345.33 13.43 85.74 89.24 86.24 84.81
Total liabilities
16.37 358.61 54.78 118.52 99.80 94.13 89.66
Additional Paid In Capital
0.29 5.61 757.00 788.99 807.16 824.78 840.94
Common Stock (Net)
0.00 — — — — — —
Retained Earnings
(7.18) (44.92) (201.72) (424.89) (580.98) (655.12) (726.49)
Common Equity (Total)
(6.89) (39.60) 555.20 363.61 225.83 169.44 113.87
Shareholders Equity (Total)
(6.89) (39.60) 555.20 363.61 225.83 169.44 113.87
Shareholders Equity and Liabilities (Total)
9.48 319.01 609.98 482.13 325.63 263.57 203.52
Shares (Common)
0.56 1.03 6.45 6.50 6.50 6.53 6.78
Shareholders Equity (Tangible)
(6.89) (55.42) 539.37 363.61 225.83 169.44 113.87
Net Debt
(8.89) (241.71) (454.10) (188.57) (70.43) (30.96) 8.51
Total Debt
— — — 72.35 81.43 84.19 84.81

Fold the line items

In millions of $ except per-share values · columns are period end dates